Praxis ownership update: 8.9% held by two institutions
Praxis Precision Medicines, Inc. ownership update: two institutional investors filed an amendment reporting combined beneficial ownership of 2,472,480 shares, representing 8.9% of common stock.
Rhea-AI Filing Summary
Praxis Precision Medicines, Inc. ownership update: two institutional investors filed an amendment reporting combined beneficial ownership of 2,472,480 shares, representing 8.9% of common stock. The filing lists sole voting and dispositive power of 2,468,413 shares for Orbis Investment Management Ltd and 4,067 shares for Allan Gray Australia Pty Ltd.
The filing classifies both reporting persons as non‑U.S. institutions equivalent to an investment adviser and disclaims group beneficial ownership between them. Signatures certify comparability of foreign regulatory schemes and willingness to furnish Schedule 13D information if requested.
Positive
- None.
Negative
- None.
Insights
Two institutions hold a reported 8.9% stake in Praxis.
The filing states combined beneficial ownership of 2,472,480 shares, with Orbis holding 2,468,413 shares of sole voting and dispositive power and Allan Gray Australia holding 4,067 shares. This is a snapshot of disclosed positions, not an offer or transfer.
Future disclosures may clarify whether these holdings change; any material change would appear in subsequent ownership filings.
Submission follows Schedule 13G/A conventions for passive institutional investors.
The amendment classifies both filers as a Non‑U.S. Institution equivalent to an Investment Adviser and includes a certification about comparable foreign regulation. The filing disclaims group status and accepts staff requests for Schedule 13D information.
Read literally: the document documents ownership and regulatory equivalence; it does not state intent to act as a group or change voting arrangements.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial ownership financial
sole dispositive power regulatory
Non‑U.S. Institution (FI) equivalent to an Investment Adviser (IA) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Orbis and Allan Gray report in PRAX?
Do the filers claim they act as a group in this 13G/A for PRAX?
What voting and dispositive powers are reported by the filers?
What regulatory statement do the reporting persons include in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.